Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle Hermiston

Showing results (31-40 of 32) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 32 results.
Blood Advances|September 30, 2025
Liberalizing hospital proximity requirements for children/young adults with low-burden B-ALL receiving tisagenlecleucelLauren E Appell, Christina Baggott, Khanh Nguyen, et al.
Frontiers in Immunology|November 15, 2023
Mediport use as an acceptable standard for CAR T cell infusionMaya Eylon, Snehit Prabhu, Samuel John, et al.
Pageof 4

Showing results (31-40 of 32) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 32 results.
Blood Advances|September 30, 2025
Liberalizing hospital proximity requirements for children/young adults with low-burden B-ALL receiving tisagenlecleucelLauren E Appell, Christina Baggott, Khanh Nguyen, et al.
Frontiers in Immunology|November 15, 2023
Mediport use as an acceptable standard for CAR T cell infusionMaya Eylon, Snehit Prabhu, Samuel John, et al.
Pageof 4